BeOne Medicines AG
ONC
$347.48
-$8.53-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 12.94% | 0.74% | |||
| Total Other Revenue | -3.19% | 20.16% | |||
| Total Revenue | 12.66% | 1.02% | |||
| Cost of Revenue | 4.37% | 17.41% | |||
| Gross Profit | 13.69% | -0.70% | |||
| SG&A Expenses | 6.87% | -0.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.22% | -3.78% | |||
| Operating Income | 30.07% | 35.06% | |||
| Income Before Tax | 20.54% | 73.69% | |||
| Income Tax Expenses | 136.84% | -61.50% | |||
| Earnings from Continuing Operations | 4.24% | 241.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.24% | 241.88% | |||
| EBIT | 30.07% | 35.06% | |||
| EBITDA | 25.81% | 31.82% | |||
| EPS Basic | 3.67% | 241.16% | |||
| Normalized Basic EPS | 18.67% | 36.18% | |||
| EPS Diluted | 6.67% | 272.56% | |||
| Normalized Diluted EPS | 19.31% | 36.00% | |||
| Average Basic Shares Outstanding | 0.56% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||